What is Triall?
Triall is a company that offers innovative software and supporting services to clinical researchers and patients involved in clinical trials—research studies that investigate the safety and efficacy of new treatments before these can enter the market.
Why was Triall founded?
Modern clinical trials involve increasing amounts of electronic systems and data. As a result, many clinical research professionals experience a lack of oversight, fragmentation, and uncertainty about the integrity and authenticity of collected research data. This reduces efficiency and reliability in the development of new medicines. These issues demonstrate the need for new tools and ways of working.
What is the background of Triall's team?
Triall brings together a team of clinical trial professionals, eClinical software developers, and emerging technology experts. Triall’s team builds on the combined experience of managing 150+ clinical trials across 30+ countries, and of managing tech-enabled startups and scaleups both in the Life Sciences and the health software industries.
What is Triall's mission?
Triall’s mission is to advance clinical trials in the digital era, making use of evidence-based innovations in information technology to promote security, quality, efficiency, and decentralised ways of collaboration among clinicians and patients.
What is Triall's vision for clinical trials?
Triall envisions a digital ecosystem for clinical trials: a decentralised collaboration environment that links different eClinical software, health information systems, and their users through a common and secure federated data infrastructure. Applying decentralised technologies and open ‘web3’ standards, this infrastructure will facilitate highly granular and tamper-resistant ways of authentication, authorisation, discovery, and exchange among ecosystem participants, while assuring security, privacy, auditability and individual control. The future digital ecosystem will open up ample opportunity for smarter, more-efficient, more-reliable and truly patient-centric clinical research.
How does Triall contribute to realising its vision for clinical trials?
Since 2018, Triall has been working with industry and academia in the design, development, and demonstration of key enabling technologies for the envisioned decentralised collaboration environment. Triall believes in making these technologies work with, instead of replacing existing systems and ways of working in the clinical trials domain. Therefore, Triall innovates on top of an existing and industry-validated eClinical technology platform, gradually adding innovative features for improved cross-system collaboration.
Who are Triall's key partners?
Triall is proud to be partnered with leading organisations in clinical research, eClinical innovation, and emerging technology.
A selection of our key partners:
Crucial Data Solutions – Founded in 2010, Crucial Data Solutions (CDS) provides the most innovative 'low-code/no-code' data and clinical trial management technology on the market today. CDS is the developer of TrialKit, a cloud-based eClinical technology platform that forms the basis for Triall’s eClinical solutions. TrialKit is being leveraged by industry leaders and innovators such as Verily Life Sciences (a subsidiary of Google’s Alphabet), ICON GPHS, FUEL Studios, Catalyst Clinical Research, SISCAPA Assay Technologies, CDx Diagnostics, Optinose, and many more. The landmark partnership with CDS enables Triall to innovate on top of a validated technology platform that is used by thousands of industry professionals globally.
Sphereon – Sphereon and Triall have a long-standing strategic partnership in research, development, and implementation of emerging technologies and standards in clinical trials. Sphereon (est. 2008) has its roots in business process management and document processing, and currently is one of the world’s leading specialists in blockchain and self-sovereign identity (SSI) technologies. Their technology solutions have established independently verifiable trust in data, documents, and processes for Public Administration, Healthcare, Mobility, Education, and other industries. Sphereon’s API-driven platform for verifiable data exchange, Sphereon VDX, enables Triall to deploy advanced solutions for storing and sharing clinical trial data in a secure, verifiable, and privacy-protective manner. Sphereon VDX is instrumental for realiing of a secure and efficient decentralied collaboration environment for clinical trials.
CR2O – Full-service contract research organisation CR2O (est. 2012) offers extensive experience in managing and implementing Phase I–IV clinical trials across a broad range of therapeutic areas and many different regions of the world. CR2O is preferred partner in large international consortium studies (e.g., Horizon 2020, CEPI, BMGF, IMI) and collaborates with leading clinics and research centers, offering access to world-class scientific expertise and patient populations. CR2O’s in-house clinical research experts work with Triall in the ideation, design, testing, and validation of innovative eClinical products and features to optimise user experience, problem-solution and product-market fit.